Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly N-acetyl glucosamine (PNAG)
- Target
- PNAG
- Molecular classification
- Exopolysaccharide, Polysaccharide
01
Overview
Poly N-acetyl glucosamine (PNAG), also known as poly-β(1,6)-N-acetylglucosamine, is a high molecular weight exopolysaccharide composed of β(1,6)-linked N-acetylglucosamine residues. It is produced by a wide range of medically important bacteria and some eukaryotic pathogens. PNAG plays a crucial role in biofilm formation, bacterial adhesion to surfaces, immune evasion, and resistance to environmental stresses, making it an attractive target for broad-spectrum vaccine development and antibody-based therapies.
- Other names
- Poly-β(1,6)-N-acetylglucosamine
02
Mechanism of action
Targeting PNAG through vaccination or antibody-based therapies to prevent biofilm formation and enhance immune clearance.
03
Biological functions
Biofilm formationCell-to-cell aggregationAdhesionImmune evasionProtection from environmental stressors
04
Disease associations
Infection
05
Safety considerations
Natural antibodies against native PNAG are generally not highly protective, requiring modified glycoforms or conjugate vaccines for effective immunity.Potential for off-target effects when targeting PNAG due to its presence in commensal bacteria or host tissues (though less likely).
Beyond the preview
Go deeper on Poly N-acetyl glucosamine (PNAG).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Poly N-acetyl glucosamine (PNAG).